ENDRA Life Sciences (NDRA) Receivables - Net (2017 - 2018)

ENDRA Life Sciences (NDRA) reported Receivables - Net of $12275.0 for Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.

ENDRA Life Sciences (NDRA) Receivables - Net (2017 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has 2 years of Receivables - Net data on file, last reported at $12275.0 in Q3 2018.

Receivables - Net for Q3 2018 came in at $12275.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $12275.0 (changed N/A YoY), and the FY2017 annual result was $6850.0, changed N/A from the prior year.
Receivables - Net advanced to $12275.0 in Q3 2018 per NDRA's latest filing, from $11770.0 in the prior quarter.
Over five years, Receivables - Net peaked at $12275.0 in Q3 2018 and troughed at $6850.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn
10	ENDRA Life Sciences	5.25 Mn	4.90 Mn	-

Download Data